SCHEMBL10132560

SCHEMBL10132560

COc1cc2ccc3c4ccc5c(c4c[n+](C)c3c2cc1OC)OCO5

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BAD Q92934 7/20 0.76
ALDH1A1 P00352 6/20 0.76
MAPT P10636 6/20 0.76
HPGD P15428 6/20 0.76
SMN1; SMN2 Q16637 6/20 0.76
MAPK1 P28482 5/20 0.76
KMT2A Q03164 5/20 0.76
KDM4E B2RXH2 4/20 0.76
MEN1 O00255 4/20 0.76
LMNA P02545 4/20 0.76
TP53 P04637 3/20 0.76
CYP3A4 P08684 3/20 0.76
ALOX15 P16050 3/20 0.76
ALOX12 P18054 3/20 0.76
HSD17B10 Q99714 3/20 0.76
BCHE P06276 3/20 0.76
ACHE P22303 3/20 0.76
RGS17 Q9UGC6 2/20 0.76
RGS12 O14924 2/20 0.76
NPC1 O15118 2/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sanguinarium SCHEMBL9651303 0.89 BAD (0.70) BADALDH1A1MAPTHPGDSMN1; SMN2
Sanguinarium SCHEMBL30129850 0.86 BAD (1.00) BADALDH1A1MAPTHPGDSMN1; SMN2
Sanguinarium SCHEMBL123241 0.86 BAD (1.00) BADALDH1A1MAPTHPGDSMN1; SMN2
Sanguinarium SCHEMBL29385229 0.86 BAD (1.00) BADALDH1A1MAPTHPGDSMN1; SMN2
Sanguinarium SCHEMBL30153784 0.86 BAD (1.00) BADALDH1A1MAPTHPGDSMN1; SMN2
Sanguinarium SCHEMBL23524622 0.86 BAD (1.00) BADALDH1A1MAPTHPGDSMN1; SMN2
Chelerythrine SCHEMBL28629157 0.86 ALDH1A1 (0.88) BADALDH1A1MAPTHPGDSMN1; SMN2
Hydrochloric Acid SCHEMBL4261974 0.85 ALDH1A1 (0.57) BADALDH1A1MAPTHPGDSMN1; SMN2
Sanguinarium SCHEMBL8584009 0.85 BAD (0.97) BADALDH1A1MAPTHPGDSMN1; SMN2
Sanguinarium SCHEMBL43290 0.85 RAC1 (1.00) BADALDH1A1MAPTHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8741917-B2 Benzo [C] phenanthridines as antimicrobial agents RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2014-06-03 US disclosed
US-20120022061-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS RUGTERS, THE STATE UNIVERSITY OF NEW JERSEY 2012-01-26 US disclosed
WO-2010083436-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2010-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022061-A1 BENZO [C] PHENANTHRIDINES AS ANTIMICROBIAL AGENTS CCNT1, XPO4, XDH BAD 384/4885ALDH1A1 3095/4885MAPT 4875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.